CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Index trend and stocks in action on May 19, 2020

DSIJ Intelligence-3 0 770 Article rating: 4.0

Nifty has retraced more than 50 per cent of the prior rise and the next major support is placed in the region of 8,756-8,800 as 61.8 per cent retracement is placed in this region. On the upside, the zone of 9,050-9,165 is likely to act as a resistance level for the index. Stocks in news: VEDL, Tata Consumer, ABFRL, Raymond.

Gap-up start for D-Street today!

DSIJ Intelligence-3 0 602 Article rating: 5.0

Indian equity markets nosedived on Monday and closed at one month low. But as Doug Kass says often, the markets have no memory from day to day. The market participants are likely to catch by surprise as SGX Nifty is indicating a strong opening this morning and helping this cause are also the firm global cues after Moderna reported that its experimental trial of COVID-19 vaccine showed promising results.

Index trend and stocks in action on May 18, 2020

DSIJ Intelligence-3 0 1300 Article rating: 3.6

The level of 9,000 would be crucial level to watch out and any move below this level, could lead to further downside towards 8,820 levels. Meanwhile, on the upside, Thursday’s gap which stands at 9,281-9,351 is likely to act as a resistance. Stocks in news: Reliance Industries, KNR Constructions, Future Consumer, Godrej Consumer Products.

Dull start for the day!

DSIJ Intelligence-3 0 1218 Article rating: 4.5

On the final trading session of the week, SGX Nifty is see-sawing near the neutral line as well as trading flat at 9,118 levels. The second tranche of economic package was unveiled by Finance Minister. She announced a host of schemes for migrant workers, street vendors, small traders and small farmers.

Federal Bank surges on announcing tie-up with MoneyGram

DSIJ Intelligence 0 3274 Article rating: 3.4

Leading private sector bank, Federal Bank Limited, joined hands with MoneyGram Payment Systems, Inc., a wholly-owned subsidiary of MoneyGram International, Inc., a global leader in cross-border P2P payments and money transfers, for a strategic partnership to offer a cost-effective direct to bank account credit option for customers in India.

Index trend and stocks in action on May 14, 2020

DSIJ Intelligence-3 0 1009 Article rating: 5.0

The low of Wednesday’s session would be crucial to watch out as sustaining below 9,350 level, could lead the index towards 9,116 levels. While on the upside, sustaining above 9,450 mark, could open gates for 100-200 points rally on the upside. Stocks in news: Datamatics Global Services, Kingfa Science & Technology, Infosys, Maruti Suzuki India, PNC Infratech.

GlobalFoundries select Infosys as digital transformation partner

DSIJ Intelligence 0 1429 Article rating: 2.3

Infosys, a global leader in the next-generation digital services and consulting, has been selected by GlobalFoundries (GF), the world’s leading speciality foundry, as its partner for the company’s digital transformation program. Through this partnership, Infosys will provide expertise and analytical solutions to optimise the overall efficiency and agility of GF’s manufacturing and business operations.

Gilead signs pact with 5 companies for COVID-19 treatment

Apurva Joshi 0 835 Article rating: 3.3

Gilead Sciences Inc. has entered into a non-exclusive licensing agreement with four Indian companies namely Cipla Ltd, Hetero Labs Ltd, Jubilant Life Sciences and Mylan and one Pakistani firm Ferozsons Laboratories. The agreement is for manufacturing and distribution of the investigational medicine Remdesivir.

Glenmark Pharma begins phase 3 clinical trial on antiviral tablet

Apurva Joshi 0 2803 Article rating: 3.5

Glenmark Pharmaceuticals Limited has initiated phase 3 clinical trials in India on antiviral tablet-Favipiravir, for which it had received an approval from India’s drug regulator-DCGI in late April. Glenmark is the first company in India to initiate phase 3 clinical trials on Favipiravir for COVID-19 patients in India.

RSS
First349350351352354356357358Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR